보험 시장의 AI - 종합 개요 (출처 없음)
요약
보험사들이 프로세스 자동화, 위험 평가 개선, 사기 감소, 그리고 더 나은 고객 경험 제공을 위해 인공지능을 도입함에 따라 보험 시장의 AI는 빠르게 성장하고 있습니다. AI는 보험 인수, 보험금 청구 처리, 유통, 가격 책정 및 운영 효율성을 혁신하여 보험 업계를 규칙 기반의 수동 워크플로에서 데이터 기반의 신속한 의사 결정으로 전환하고 있습니다.
시장 개요
이 시장은 이미 전 세계적으로 수십억 달러 규모이며, 클라우드 도입, 데이터 가용성, 머신러닝(ML) 툴이 성숙함에 따라 향후 5~10년 동안 빠르게 성장할 것으로 예상됩니다.
비용 절감, 신속한 보험금 청구 처리, 개인 맞춤형 상품, 사기 탐지 개선에 대한 수요 증가가 성장을 견인하고 있습니다.
Forecast projections indicate continued expansion of the Pompe Disease Treatment Market over the coming decade. For example, one source projects growth from USD 1.14 billion in 2023 to USD 1.54 billion by 2032, a CAGR of around 3.3%, while others forecast a climb from USD 1.50 billion (2024) to USD 1.95 billion (2030) at 4.4% CAGR. More aggressive estimates see the market reaching over USD 2.7 billion by 2030 at 7.3% CAGR. These forecasts, compiled in the Pompe Disease Treatment Market forecast, reflect how tablets, combination ERTs, and gene therapies could fuel sustained growth—especially with newborn screening and favorable policy landscapes accelerating patient detection.
Forecast scenarios vary by modality: ERT remains dominant, but oral agents and gene-based platforms are gaining share. Clinical success of therapies like cipaglucosidase alfa with miglustat (approved in the EU and US in 2023) and licensure of avalglucosidase alfa (Nexviazyme) are key catalysts. Additionally, policies enabling orphan drug incentives and value-based…
The Medical Imaging Workstations Market forecast reveals sustained growth driven by increasing imaging volumes, regulatory pressures for faster turnaround times, and evolving clinical demands. As imaging modalities grow more complex (e.g., high-resolution CT angiography and functional MR), the need for high-performance workstations increases. The forecast envisions expansion across standalone radiology suites and interventional hybrid rooms—where imaging data must be displayed and manipulated in real-time. This trend toward versatility and performance is reflected in projections for the Medical Imaging Workstations Market forecast, with adoption expected to accelerate in both developed and emerging markets.
Clinicians are also embracing collaborative tools that allow simultaneous review of imaging studies across departments or remote sites—enabled by secure cloud platforms and zero-footprint viewers. Economics play a role too: vendors are offering subscription-based software models, offsite support, and upgrade paths that reduce capital strain on health systems. Coupled with teleradiology expansion, these models broaden access while enhancing scalability.…
The Neurodegenerative Disease Market forecast highlights robust growth driven by technological innovations, government initiatives, and increased awareness of neurological disorders. Rising healthcare investments are enabling new treatment pathways, including regenerative therapies and neuroprotective drugs. Genetic studies are improving understanding of disease mechanisms, which is critical for drug discovery. This progress is essential, given the expected rise in dementia cases worldwide. Clinical research continues to focus on therapies that can slow down or halt disease progression, an unmet need in the healthcare system. As awareness improves, early diagnosis and intervention become possible, which in turn contributes to a stronger Neurodegenerative Disease Market forecast.
Market expansion is not just limited to developed economies. Emerging regions are witnessing rapid improvements in healthcare infrastructure and patient access. With the integration of machine learning and big data, researchers are unlocking new biomarkers and patient insights. Increasing collaborations between pharma companies and research institutes are further ensuring…